← SynDRA
DEFACTINIB
SynDRA canonical compound SYN0037861 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | PTK2 |
| Mechanism of action | Focal adhesion kinase inhibitor |
All known targets
Mechanisms of action (all sources)
- FAK inhibitor
- PTK2 INHIBITOR
- Focal adhesion kinase 1 inhibitor
- PTK2B INHIBITOR
- Protein tyrosine kinase 2 beta inhibitor
- LATS1 INHIBITOR
Cross-references
Synonyms
- VS-6063
- DEFACITINIB
- DEFACTINIB (VS-6063)
- Defactinib hydrochloride
- PF-04554878
- PF 04554878
- VS 6063
- Defactinib (VS-6063, PF-04554878)
- N-methyl-4-((4-(((3-(N-methylmethylsulfonamido)pyrazin-2-yl)methyl)amino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)benzamide
- N-methyl-4-[[4-[[3-[methyl(methylsulfonyl)amino]pyrazin-2-yl]methylamino]-5-(trifluoromethyl)pyrimidin-2-yl]amino]benzamide
- 53O87HA2QU
- Benzamide, N-methyl-4-((4-(((3-(methyl(methylsulfonyl)amino)-2-pyrazinyl)methyl)amino)-5-(trifluoromethyl)-2-pyrimidinyl)amino)-
- VS6063
- N-Methyl-4-((4-(((3-(methyl(methylsulfonyl)amino)pyrazin-2-yl)methyl)amino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)benzamide
- N-methyl-4-((4-(((3-methyl(methylsulfonyl)aminopyrazin-2-yl)methyl)amino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)benzamide
- Defactinib [USAN:INN]
- UNII-53O87HA2QU
- Defactinib [USAN]
- DEFACTINIB [INN]
- Defactinib (USAN/INN)
- DEFACTINIB [WHO-DD]
- GTPL7910
- SCHEMBL1627234
- CHEMBL3137331
- BDBM418817
- DTXSID901025937
- HMS3740O13
- AMY42170
- BCP11299
- EX-A1037
- EX-A1049
- MFCD25977806
- NSC778364
- NSC781450
- NSC782549
- NSC800089
- s7654
- US10450297, Example 317
Look up DEFACTINIB in the interactive SynDRA portal →